Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOOM
NCT00395135Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2006
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity comparing Lorcaserin 10 mg BID with Matching Placebo BID (2 arms). Primary endpoints: Proportion of Patients Achieving >= 5% Weight Loss From Baseline to Week 52 and Proportion of Patients Maintaining >= 5% Weight Loss at Week 104. Started Nov 2006; status: completed.
02
Drugs
lorcaserin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00395135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395135.